FICKENSCHER JAMES E (Chief Financial Officer) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/25/2021ACC: 0001192482-21-000114
Officer· Chief Financial Officer
Since Aug 2018
+130K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
130K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+52K
Price / share
—
Trade value
—
% of position
251.0%
1/21/2021
20.72K→72.72K
Total
Net shares
+52K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2021 | A · Award | +52K | — | — | 251.0% | 20.72K | 72.72K |
| Total | +52K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
78K shares
Shares
+78K
Strike price
3.58
Held after
78K
Exercisable
—
1/21/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock78K shares | 1/21/2021 | A · Award | +78K | 3.58 | — | 78K |